ODDB.org: Open Drug Database

Desitin Pharma GmbH - Ospolot 20 mg/ml, Suspension zum Einnehmen

Swissmedic Registration	69828	Sequence	01
Product name	Ospolot 20 mg/ml	Description	Suspension zum Einnehmen
ATC-Classification	N03AX03	ATC-Description	Sultiame
Introduction of Sequence	05.08.2025

Composition

sultiamum 20 mg, E 219 2.3 mg, propylis parahydroxybenzoas natricus 0.6 mg, sucralosum, natrii docusas, xanthani gummi, natrii dihydrogenophosphas dihydricus, dikalii phosphas anhydricus, aromatica (Erdbeer), aromatica (Geschmacksmodulator) cum E 220 et fructosum et glucosum et saccharum, aromatica (Aroma zur Geschmacksmaskierung), acidum phosphoricum concentratum, aqua purificata ad solutionem pro 1 ml corresp. natrium 0.667 mg.

Packungsbestandteile

Galenic Form

Suspension (oral)

Excipiens

Active Agent	Dose
Sultiam	20 mg/ml

BAG: Active Agent	Dose
Sultiam	20 mg

Inactive agents	Dose	additional_information
Acidum Phosphoricum Concentrate
Aqua Purificata
Aromatica (Aroma zur Geschmacksmaskierung)
Aromatica (Erdbeer)
Aromatica (Geschmacksmodulator) cum E	220
Dipotassium Phosphate Anhydrate
E 219	2.3 mg/ml	conserv.
Fructosum
Glucose
Sodium Dihydrogenophosphate Dihydrate
Natrii Docusas
Propylis Parahydroxybenzoas Natricus	0.6 mg/ml
Saccharum
Sucralosum
Xanthani Gummi

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	250 ml	96.52	121.40	B	SL	No

2026	©ywesee GmbH